Notícias · Recifes

New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant s

New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.

Admin Recifes 15/07/2026 2

Data demonstrate 1-year survival of stem cell-derived neural progenitor cells in patients

New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal transplantation in patients with retinitis pigmentosa (RP), while maintaining a favorable

Admin Recifes 15/07/2026 2

GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula

Admin Recifes 15/07/2026 3

Researchers uncover hormone link between gut and brain in anorexia nervosa

People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026. Patients with the highest lev

Admin Recifes 15/07/2026 2

FDA expands use of first sickle cell disease gene therapy for children as young as 2 years

The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplement

Admin Recifes 15/07/2026 2

Researchers expand plasmonic liquid biopsy platform to early-stage colorectal cancer

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health Materials Research Division has developed a plasmonic-based liquid biopsy platform capable of ultrasensitive detection of KRAS mutations in the blood and urine of

Admin Recifes 15/07/2026 1

New study highlights potential challenges for using automated AI tools in health care

In experiments in which physicians made decisions about treating hypothetical patients, the physicians tended to trust incorrect advice presented as being generated by artificial intelligence (AI), even after being given the opportunity to notice that patient recovery data contra

Admin Recifes 15/07/2026 2

50 million Americans live in counties without a radiation oncology clinic, study finds

More than 50 million Americans live in counties without a radiation oncology practice site, and millions more are at risk, according to a new study published today in the International Journal of Radiation Oncology*Biology*Physics (Red Journal), the flagship journal of the Americ

Admin Recifes 15/07/2026 2

Eco-friendly spiderweb-inspired pressure sensor for robotic hands may assist patients with

A high-performance biodegradable pressure sensor has been developed as a key technology for wearable AI health care robotics and user-friendly robotic systems.

Admin Recifes 15/07/2026 2

Hidden pocket reveals new way to target prostate cancer's 'undruggable' ERG protein

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in which the genes TMPRSS2 and ERG are fused together. This causes the ERG protein t

Admin Recifes 15/07/2026 2

Study explores the emotional burden of being a family caregiver

One in four Canadians is a caregiver—often taking on the role overnight, with little time to prepare for what comes next. Sharon Tonner-Clarkson, a patient family partner (PFP) at Unity Health Toronto, knows that reality all too well. Her mother was diagnosed with osteoporosis af

Admin Recifes 15/07/2026 2

Bimekizumab well tolerated, efficacious over three years in axial spondyloarthritis

For patients with axial spondyloarthritis (axSpA), bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over three years, according to a study published in the June issue of the Journal of Rheumatology.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes